Ovid Therapeutics Inc. ( OVID) - Stock Earnings
OVID Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
OVID Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 9.7 million USD | 718000 USD |
| 2026Q1 | -17.0 million USD | — USD |
| 2026Q2 | -15.0 million USD | 733000 USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
OVID Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -52.3 million USD | 392000 USD |
| 2024 | -26.4 million USD | 566000 USD |
| 2025 | -17.4 million USD | 7.3 million USD |
| 2026 Est. | — | — |
OVID
Price: $2.15
52 week price:
Earnings Per Share: -0.22 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 61100
Ebitda: -9.4 millionMarket Capitalization: 444.2 million